Clare Kahn - Dec 13, 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role
Director
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Clare Kahn
Stock symbol
SLDB
Transactions as of
Dec 13, 2022
Transactions value $
$0
Form type
4
Date filed
12/15/2022, 05:10 PM
Previous filing
Jun 9, 2022
Next filing
Jun 8, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLDB Director Stock Option (Right to Buy) Award $0 +9.65K $0.00 9.65K Dec 13, 2022 Common Stock 9.65K $6.47 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option was granted on December 13, 2022 and vests in full on the one-year anniversary of the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.

Remarks:

Exhibit Index: 24.1 Power of Attorney